Bibliography
- Yao L, Zhang R, Mao S, Use of antibiotics in Shanghai second and third level hospitals during the period of 2007 – 2008. Eval Analyst Drug Hosp China 2010;10:971-3; in Chinese
- Li C, Xu L, Jiao H. Application analysis of antibiotics in our hospital in 2009. Chin J Drug Appl Monit 2010;7:293-4; in Chinese
- Zhao ZH, Jing WL, Wang XY, Relationship of antibacterials use and bacterial drug resistance in hospitalized patients. Chin J Nosocomiol 2010;20:3017-19; in Chinese
- Shi ZH, Xiao ZP, Tan LM, Analysis of 612 cases of antibiotics-induced ADR in our hospital. Chin Pharm 2010;21:3615-17; in Chinese
- Camille S, Johanna G. Principles of selection and use of antimicrobial agents. Semin Pediatr Infect Dis 1999;10:3-13
- Welte T, Pletz MW. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Int J Antimicrob Agents 2010;36:391-400
- Trontell AE. How the US Food and Drug Administration defines and detects adverse drug events. Curr Ther Res Clin Exp 2001;62:641-9
- Montastruc JL, Sommet A, Lacroix I, Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Joint Bone Spine 2006;73:629-32
- Hohl CM, Nosyk B, Kuramoto L, Outcomes of emergency department patients presenting with adverse drug events. Ann Emerg Med 2011;58:270-9
- Johansson SGO, Bieber T, Dahl R, Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6
- Doherty MJ. Algorithms for assessing the probability of an adverse drug reaction. Respir Med 2009;2:63-7
- Robert C, Owens Jr. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbilo Infect Dis 2008;61:110-28
- Jin K, Wang S, Huang Z, Clostridium difficile infections in China. J Biomed Res 2010;24:411-16
- Paterson DL, Ko WC, Von Gottberg A, Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extendedspectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206-12
- Courpon-Claudinon A, Lefort A, Panhard X, Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 2011;17:557-65
- With KD, Bergner J, Buhner R, Antibiotic use in German university hospitals 1998–2000 (Project INTERUNI-II). Int J Antimicrob Agents 2004;24:15-20
- Pluss-Suard C, Pannatier A, Kronenberg A, Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. J Hosp Infect 2011;79:166-71
- Owens RC, Ambrose PG. Antimicrobial stewardship and the role of pharmacokinetics–pharmacodynamics in the modern antibiotic era. Diagn Micr Infect Dis 2007;57:S77-83
- Isturiz RE. Optimizing antimicrobial prescribing. Int J Antimicrob Agents 2010;36:S19-22
- Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ 2011;30:933-49
- Buke AC, Ermertcan S, Hosgor-Limoncu M, Rational antibiotic use and academic staff. Int J Antimicrob Agents 2003;21:63-6
- Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Micr Infect Dis 1995;22:89-96
- Mitropoulos IF, Rotschafer JC, Rodvold KA. Adverse events associated with the use of oral cephalosporins/cephems. Diagn Micr Infect Dis 2007;57:S67-76
- Singh J, Arrieta AC. New cephalosporins. Semin Pediatr Infect Dis 1999;10:14-22
- Burt R. Meyers. Cefaclor revisited. Clin Ther 2000;22:154-66
- Antunez C, Blanca-Lopez N, Torres MJ, Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immun 2006;117:404-10
- Campagna JD, Bond MC, Schabelman E, The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med 2011;35:1-9